Tuberculosis, lung infections, interstitial lung disease, and socioeconomic issues in AJRCCM 2001. (Q34550149)

3 August 2017

1 reference

title

Tuberculosis, lung infections, interstitial lung disease, and socioeconomic issues in AJRCCM 2001. (English)

1 reference

interstitial lung disease

3 August 2017

0 references

1 reference

1 reference

Martin J Tobin

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

165

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

631-641

1 reference

Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Tuberculosis transmission--rogue pathogen or rogue patient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Tuberculosis in the foreign-born population of Tarrant county, Texas by immigration status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Controlling tuberculosis among foreign born within industrialized countries: expensive band-aids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Diagnosing latent tuberculosis infection: the 100-year upgrade

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Changing approaches to the diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Antiapoptotic effects of IL-15 on pulmonary Tc1 cells of patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Prevalence of bronchial hyperresponsiveness among HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Polymyositis-dermatomyositis-associated interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Clinical characteristics of patients in a case control study of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

The ACCESS study: characterization of sarcoidosis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Depression in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Examining the link between sarcoidosis and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Chromosome 16 Loss of Heterozygosity in Tuberous Sclerosis and Sporadic Lymphangiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Reversible Airflow Obstruction, Proliferation of Abnormal Smooth Muscle Cells, and Impairment of Gas Exchange as Predictors of Outcome in Lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Role of molds in farmer's lung disease in Eastern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Pseudoasbestos bodies and fibers in bronchoalveolar lavage of refractory ceramic fiber users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Rapid declines in FEV1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Longitudinal changes in pulmonary function and respiratory symptoms in cotton textile workers: a 15-yr follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Role of snoring and daytime sleepiness in occupational accidents

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

When the chest X-ray does not tell the whole story: a tale of miners, selection bias, and the healthy worker effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Respiratory health in a globalizing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Rip Van Winkle: will academic pulmonary programs ever wake up to sleep?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

Repeat Tuberculin Testing in BCG-vaccinated Subjects in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.5.2201064

10.1164/AJRCCM.165.5.2201064

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference